Predictive Genetic Testing in the Cancer Management and Prevention
Journal of Cancer Science and Clinical Therapeutics · 2025 · 9 (4)
DOI: 10.26502/jcsct.5079274 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cancer Science and Clinical Therapeutics, 2025. Verfasst von Niayesh Najafi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Research, College of the Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, California, …. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS.
Abstract (Originalsprache)
Predictive genetic testing is a medical test that can effectively reduce morbidity and mortality caused by genetic diseases. This specific test predicts the risk of disease and provides prognostic information in asymptomatic persons, leading to the adoption of prevention strategies and individualized treatment in high-risk persons. Although the cause of some cancers is not known correctly, numerous studies establish that some specific gene mutations make people susceptible to specific cancer. Therefore, genetic screening of people, especially individuals with a family history of cancer, can be essential in reducing disease mortality and improving survival. Although genetic screening, in some cases, is associated with challenges, overall, it can be recognized as an important way to prevent and control hereditary diseases and save many lives. This article provides a critical review of the published reports and discusses the value of preventive genetic testing in preventing and controlling cancers and the role of hereditary mutations associated with cancer development.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Translational Research, College of the Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, California, USA.
- Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
- Brainstim Centers, Calabasas, California.
Förderung
- NIAID NIH HHS
Zitieren
APA
Najafi, N., Sasaninia, K., Najafi, Z., Babakhan Vartanian, C., Babakhan Vartanian, K., Dungore, F., & Agrawal, D. K. (2025). Predictive Genetic Testing in the Cancer Management and Prevention. Journal of Cancer Science and Clinical Therapeutics, 9(4). https://doi.org/10.26502/jcsct.5079274
Vancouver
Najafi N, Sasaninia K, Najafi Z, Babakhan Vartanian C, Babakhan Vartanian K, Dungore F, et al. Predictive Genetic Testing in the Cancer Management and Prevention. Journal of Cancer Science and Clinical Therapeutics. 2025;9(4). doi:10.26502/jcsct.5079274
BibTeX
@article{Najafi2025,
author = {Najafi, Niayesh and Sasaninia, Kayvan and Najafi, Zoya and Babakhan Vartanian, Cady and Babakhan Vartanian, Kevin and Dungore, Faredun and Agrawal, Devendra K},
title = {Predictive Genetic Testing in the Cancer Management and Prevention},
journal = {Journal of Cancer Science and Clinical Therapeutics},
year = {2025},
volume = {9},
number = {4},
doi = {10.26502/jcsct.5079274}
}
EUVIMED